SORRENTO THERAPEUTICS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.013 USD | +6,400.00% |
|
+8.33% | -89.47% |
| Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
| Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
Quotes 5-day view
End-of-day quote OTC Markets| 2024-05-14 | 2024-05-15 | 2024-05-16 | 2024-05-17 | 2024-05-20 | |
|---|---|---|---|---|---|
| Last | 0.0135 $ | 0.013 $ | 0.012 $ | 0.0002 $ | 0.013 $ |
| Volume | 60 535 | 122 468 | 50 515 | 115 821 | 68 939 |
| Change | +12.50% | -3.70% | -7.69% | -98.33% | +6,400.00% |
| Opening | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| High | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
| Low | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
Performance
| 1 day | +6,400.00% | ||
| 1 week | +8.33% | ||
| Current month | -18.75% | ||
| 1 month | -35.00% | ||
| 3 months | -58.06% | ||
| 6 months | -74.00% | ||
| Current year | -89.47% | ||
| 1 year | -95.87% | ||
| 3 years | -99.82% | ||
| 5 years | -99.64% | ||
| 10 years | -99.75% |
Volumes
marketsDaily volume
68 939
Avg. Volume 20 sessions
131 554
Avg. Volume 20 sessions USD
1 710.20
Record volume 1
507 617 300
Record volume 2
303 549 800
Record volume 3
297 283 000
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
108 742
Net sales (USD)
62 839 000
Number of employees
949
Sales / Employee (USD)
66 216
Free-Float
97.77 %
Free-Float capitalization (USD)
109 274
Average Daily Capital Traded
1.57%
Highs and lows
1 week
0.00
0.02
1 month
0.000.03
Current year
0.000.14
1 year
0.000.42
3 years
0.0011.07
5 years
0.0019.39
10 years
0.0026.80
Indicators
Moving average 5 days
0.01
Moving average 20 days
0.01
Moving average 50 days
0.02
Moving average 100 days
0.04
Price spread / (MMA5)
-23.08%
Price spread / (MMA20)
-23.08%
Price spread / (MMA50)
+53.85%
Price spread / (MMA100)
+207.69%
STIM
RSI 9 days
49.34
RSI 14 days
47.90
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +6,400.00% | +8.33% | -89.47% | -95.87% | 109K | ||
| +0.15% | +3.71% | +9.58% | +30.49% | 115B | ||
| +0.51% | +1.06% | +12.41% | +30.07% | 106B | ||
| -1.56% | -3.82% | -2.59% | -13.36% | 21.96B | ||
| +2.05% | -0.27% | -12.38% | -13.17% | 21.87B | ||
| +0.74% | +1.90% | -5.29% | -27.68% | 19.21B | ||
| +0.85% | +7.49% | -3.35% | -25.06% | 18.08B | ||
| -0.45% | -3.23% | -38.57% | -33.48% | 17.71B | ||
| -0.45% | +4.04% | +7.51% | +50.60% | 14.32B | ||
| -0.42% | -0.66% | +35.67% | -12.25% | 12.42B | ||
| +0.60% | +5.72% | -24.50% | -34.85% | 8.23B | ||
| +1.82% | +15.57% | +20.91% | +57.43% | 8.11B | ||
| -0.12% | -0.02% | -0.83% | +29.54% | 7.67B | ||
| -0.14% | -4.23% | -52.57% | -66.69% | 7.49B | ||
| +0.77% | -6.68% | +262.79% | +193.93% | 7.39B | ||
| -0.04% | -8.29% | -3.87% | +33.94% | 6.95B | ||
| Average | +400.27% | +0.19% | +7.22% | +6.47% | ||
| Weighted average by Cap. | +0.29% | +1.90% | +8.35% | +17.02% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -89.47% | ||
| 2023 | -86.06% | ||
| 2022 | -80.95% | ||
| 2021 | -31.87% | ||
| 2020 | +101.92% | ||
| 2019 | +40.83% | ||
| 2018 | -36.84% | ||
| 2017 | -22.45% | ||
| 2016 | -43.74% | ||
| 2015 | -13.51% | ||
| 2014 | +24.32% | ||
| 2013 | +116.00% | ||
| 2012 | -25.00% | ||
| 2011 | -66.67% | ||
| 2010 | -68.75% | ||
| 2009 | +284.00% |
- Stock Market
- Equities
- SRNE Stock
- Quotes Sorrento Therapeutics, Inc.